brain ischemia/hypoxia

O link é salvo na área de transferência

Escolha o tipo de classificação

Página 1 a partir de 25 resultados

Piperidine compounds for treating anoxia, cerebral ischemia migraine or epilepsy

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

The present invention relates to therapeutically active piperidine compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the treatment of anoxia, traumatic injury, ischemia, migraine and epilepsy. It is well known

Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for treating cardio-cerebrovascular anoxemia

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

TECHNICAL FIELD The present invention relates to the use of N-acetyl-D-glucosamine and pharmaceutical acceptable salts thereof in the manufacture of a medicament for resisting cardiac and cerebral ischemia as well as oxygen-deficiency. BACKGROUND ART The cardiac and cerebral ischemia as well as

Agents for treatment of brain ischemia

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND OF THE INVENTION This invention pertains to heterocyclic carbon compounds having drug and bio-affecting properties and to their preparation and use. In particular, the invention is concerned with 1,4-disubstituted piperazine derivatives wherein one substituent is a 5-halopyrimidin-2-yl

Treatment of cerebral ischemia

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

FIELD OF THE INVENTION The present invention relates to the field of medicine. It provides new compositions and methods for treating or protecting individuals in need thereof from cerebral ischemia or hypoxia. The invention also relates to new compositions and methods for treating stroke. More

N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

FIELD OF THE INVENTION This invention is in the field of medicinal chemistry. In particular, this invention relates to N,N'-disubstituted guanidine analogues, and to compounds and pharmaceutical composition comprising the same, which possess neuroprotective capability. This invention further relates

N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

Amino acid derivatives of substituted quinoxaline 2,3-dione derivatives as glutamate receptor antagonists

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND OF THE INVENTION This invention is for novel glutamate receptor antagonists which are new compounds of the 5,6,7,8-substituted quinoxaline 2,3-dione type. The fused ring system is substituted at the a- or b-position by amino acid derivatives. The compounds are active as excitatory amino

Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND OF THE INVENTION This invention is for novel glutamate receptor antagonists which are new compounds of the 5,6,7,8-substituted quinoxaline 2,3-diones type. The fused ring system is substituted at the a- or b-position by amino acid derivatives. The compounds are active as excitatory amino

Substituted quinoxaline-2-ones as glutamate receptor antagonists

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND OF THE INVENTION This invention is for novel glutamate receptor antagonists which are new compounds of the substituted quinoxaline 2-ones type. The compounds are active as excitatory amino acid receptor antagonists acting at glutamate receptors, including either or both

Sulfonamide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND OF THE INVENTION The present invention concerns novel sulfonamide derivatives of substituted quinoxaline 2,3-diones having utility as glutamate receptor antagonists. The fused ring quinoxaline 2,3-dione system is substituted at the a- or b-position by sulfonamide derivatives. The

Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND OF THE INVENTION This invention is for novel glutamate receptor antagonists which are new compounds of the 5,6,7,8-substituted quinoxaline 2,3-diones type. The fused ring system is substituted at the a or b position by amino acid derivatives. The compounds are active as excitatory amino

Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemia

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to methods for preconditioning and/or providing neuroprotection to the animal central nervous system against ischemia, neurodegeneration, trauma and metal poisoning, including associated cognitive, behavioral and

Optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

FIELD OF THE INVENTION The present invention relates to some new optically active clausenamide derivatives, process of the preparation thereof, a pharmaceutical composition containing the same and their medical use, particularly their use in the respects of hypoxia protective, nootropic and

Compositions having neuroprotective and analgesic activity

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

FIELD OF THE INVENTION This invention involves means for treating neuronal injury and achieving analgesia by administration of compositions containing compounds of the formula: ##STR2## wherein R.sup.1 and R.sup.2 are alkyl having 1-8 carbon atoms. BACKGROUND OF THE INVENTION Compounds having an

Compositions having neuroprotective and analgesic activity

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

Junte-se à nossa
página do facebook

Herbal & Natural Medicine

O mais completo banco de dados de ervas medicinais apoiado pela ciência

Funciona em 55 idiomas
Curas herbais apoiadas pela ciência
Reconhecimento de ervas por imagem
Mapa GPS interativo - marcar ervas no local (em breve)
Leia publicações científicas relacionadas à sua pesquisa
Pesquise ervas medicinais por seus efeitos
Organize seus interesses e mantenha-se atualizado com as notícias de pesquisa, testes clínicos e patentes

Digite um sintoma ou doença e leia sobre ervas que podem ajudar, digite uma erva e veja as doenças e sintomas contra os quais ela é usada.
* Todas as informações são baseadas em pesquisas científicas publicadas